Table 2.
Baseline demographics, laboratory findings, and chief features of the patients from case reports and case series
| Demographic | Prevalence* (%) | Median (IQR) |
|---|---|---|
| Age, years | – | 55.5 (44.8–62.3) |
| Sex | ||
| Male | 3/10 (30.0) | – |
| Female | 7/10 (70.0) | – |
| Country of origin | ||
| Ecuador | 3/10 | – |
| Bolivia | 1/10 | – |
| India | 1/10 | – |
| Italy | 1/10 | – |
| Peru | 1/10 | – |
| Spain | 1/10 | – |
| Nicaragua | 1/10 | – |
| Honduras | 1/10 | – |
| Initial symptoms | ||
| Fever | 4/10 (40.0) | – |
| Cough | 3/10 (30.0) | – |
| Pruritus | 2/10 (20.0) | – |
| Rash | 1/10 (10.0) | – |
| COVID-19 severity | ||
| Mild | 1/10 (10.0) | – |
| Severe | 4/10 (40.0) | – |
| Critical illness | 5/10 (50.0) | – |
| Strongyloides infection status | ||
| Hyperinfection | 6/10 (60.0) | – |
| Dissemination | 2/10 (20.0) | – |
| Not specified | 2/10 (20.0) | – |
| Strongyloides testing | ||
| Stool microscopy | 4/10 (40.0) | – |
| Stool culture | 1/10 (10.0) | – |
| Serology | 4/10 (40.0) | – |
| Bronchoalveolar lavage | 1/10 (10.0) | – |
| Sputum gram stain | 1/10 (10.0) | – |
| Laboratory findings | ||
| Leukocytosis, 103/μL | 6/10 (60.0) | 15.6 (11.0–29.6) |
| Eosinophilia, % | 6/10 (60.0) | 0.54 (0.075–7.5) |
| COVID-19 treatment | ||
| Prednisone equivalent ≥ 40 mg/day | 7/10 (70.0) | – |
| Prednisone equivalent < 40 mg/day | 1/10 (10.0) | – |
| Prolonged corticosteroid > 2 weeks | 1/10 (10.0) | – |
| No corticosteroids | 1/10 (10.0) | – |
| Biologics | 3/10 (30.0) | – |
| Strongyloides treatment | ||
| Ivermectin single dose | 1/10 (10.0) | – |
| Ivermectin for 2 days | 3/10 (30.0) | – |
| Ivermectin for 3–7 days | 2/10 (20.0) | – |
| Ivermectin for > 7 days | 1/10 (10.0) | – |
| Ivermectin for unknown duration | 1/10 (10.0) | – |
| Albendazole along with ivermectin | 2/10 (20.0) | – |
| ICU admission | 5/10 (50.0) | – |
| Death | 0 (0) | – |
COVID-19 = coronavirus disease 2019; ICU = intensive care unit; IQR = interquartile range; WBC = white blood cell.
*
Defined as the number of cases reported the variable divided by the number of the total cases.